Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a new animal drug application filed by Intervet, Inc. that provides for a prescription-only, injectable porcine zinc insulin product for reducing hyperglycemia and hyperglycemia-associated clinical signs in dogs with diabetes mellitus. To view this final rule, click here.
